Related Experiment Video
Updated: Nov 6, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Suicide Attempt in a Patient with Sibutramine Associated Psychosis
Pedro Câmara Pestana1, Carla Ferreira2, Ana Luísa Santos3
1Department of Psychiatry and Mental Health. Hospital de Santa Maria. Centro Hospitalar Lisboa Norte. Lisboa; Department of Psychiatry. Faculty of Medicine. University of Lisbon. Lisboa. Portugal.
Abstract:
Sibutramine is a serotonin-norepinephrine-dopamine reuptake inhibitor, initially developed as a potential antidepressant and later approved for the management of obesity. Sibutramine use is also associated with psychiatric symptoms, namely mania, panic attacks, and, less frequently, psychosis. We report the case of a 32-year-old man, admitted to our hospital due to a suicide attempt in the context of sibutramine-associated psychosis. The symptoms remitted completely after discontinuation of sibutramine and a brief period of antipsychotic medication. The aim of this manuscript is to highlight the importance of the recognition of sibutramine-associated psychosis, to discuss the possible pathophysiology and the proper clinical and therapeutic management.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Antidepressant Drugs: MAOIs and Other Agents
Bulimia Nervosa
Psychosis and Antipsychotic Drugs: Overview
Drug Therapy
Antianxiety Medications
Acute Coronary Syndrome IV: Interprofessional Care

